Express Scripts Holding Upgraded to “Buy” by Monness Crespi & Hardt (ESRX)
Express Scripts Holding (NASDAQ:ESRX) was upgraded by analysts at Monness Crespi & Hardt from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Stock Ratings Network.com reports.
Other equities research analysts have also recently issued reports about the stock. Analysts at Citigroup Inc. initiated coverage on shares of Express Scripts Holding in a research note on Tuesday. They set a “buy” rating on the stock. Separately, analysts at Jefferson Research upgraded shares of Express Scripts Holding from a “hold” rating to a “buy” rating in a research note on Friday, February 14th. Finally, analysts at Credit Suisse raised their price target on shares of Express Scripts Holding from $75.00 to $83.00 in a research note on Friday, January 17th. Six investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $72.94.
Shares of Express Scripts Holding (NASDAQ:ESRX) opened at 76.68 on Wednesday. Express Scripts Holding has a 52 week low of $54.57 and a 52 week high of $77.40. The stock has a 50-day moving average of $73.47 and a 200-day moving average of $66.97. The company has a market cap of $61.789 billion and a P/E ratio of 34.51.
Express Scripts, Inc is a pharmacy benefit management (NASDAQ:ESRX) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.